Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Recruiting · NCT06252129 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Control groupSubjects undergoing a lung specimen lymph node dissection
What this trial is about
Lung cancer patients undergoing upfront surgery, highly benefit from a systematic lymph node dissection in the mediastinum and in the surgical specimens. The latter is performed by the pathologist. Developing a standardized technique to dissect the lobectomy specimen has the potential of maximizing the retrieval of all N1 stations lymph nodes. The investigators believe that the adoption of such technique will improve lung cancer staging and identify a higher number of patients that qualify for adjuvant therapies.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Subjects with a lung nodule or mass who are eligible to undergo a lobectomy.
- Subject without any metastasis present.
- Subjects who have peripheral lung nodule location
- Subjects must be 18 years of age or older.
Exclusion criteria
- Subjects who received preoperative chemotherapy or radiotherapy.
- Subjects who have a lung nodule located in a central location. Central tumors are defined by those infiltrating the lobar airway.
Where it is running
1 location listed across 1 US state.
- Brigham and Womens Hospital - Boston, Massachusetts, United States